Clinical trial
Topical Imiquimod for Bowen's Disease of the Head and Neck
NCT00384124 · Brooke Army Medical Center, U.S. Fed · Unknown status
Key facts
| NCT number | NCT00384124 |
|---|---|
| Title | Topical Imiquimod for Bowen's Disease of the Head and Neck |
| Official title | Phase III Trial of 6 Weeks of Imiquimod for the Treatment of Bowens Disease of the Head and Neck. Outcome is Histologic Clearance at 14 Weeks. |
| Lead sponsor | Brooke Army Medical Center, U.S. Fed |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Bowens Disease |
| Intervention type | Drug |
| Interventions | Imiquimod |
| Enrollment | 50 |
| Start date | Nov 1, 2006 |
| Primary completion | Nov 1, 2008 |
| First posted | Oct 5, 2006 |
| Last update posted | Mar 26, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: